Loading clinical trials...
Loading clinical trials...
A Comparative Study of Diosmin-Hesperidin and Loratadine for the Prevention of G-CSF Induced Bone Pain in Patients With Hematological Malignancies
Conditions
Interventions
Loratadine
Diosmin-Hesperidin
+1 more
Locations
1
Egypt
Alexandria University Hospitals
Alexandria, Egypt
Start Date
March 1, 2025
Primary Completion Date
March 1, 2026
Completion Date
July 1, 2026
Last Updated
December 29, 2025
NCT05537896
NCT05417971
NCT05735717
NCT05529069
NCT07257419
NCT06056297
Lead Sponsor
Alexandria University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions